Hochschulschrift
Studies on normal and oncogenic kit receptor signaling in primary murine mast cells and gastrointestinal stromal tumors
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
Ulm, Univ., Diss., 2005
- Keyword
-
Rezeptor-Tyrosinkinase
Imatinib mesilat
- Creator
-
Ehlers, Imke
- URN
-
urn:nbn:de:bsz:289-vts-54291
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:58 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Object type
- Hochschulschrift
Associated
- Ehlers, Imke
Other Objects (12)
Motesanib inhibits Kit mutations associated with gastrointestinal stromal tumors
TAS-116 inhibits oncogenic KIT signalling on the Golgi in both imatinib-naïve and imatinib-resistant gastrointestinal stromal tumours
Coordinated targeting of CK2 and KIT in gastrointestinal stromal tumours
Germline mutations of KIT in gastrointestinal stromal tumor (GIST) and mastocytosis
Anti-KIT designer T cells for the treatment of gastrointestinal stromal tumor
THZ1 targeting CDK7 suppresses c-KIT transcriptional activity in gastrointestinal stromal tumours
Efficacy of SCF drug conjugate targeting c-KIT in gastrointestinal stromal tumor
Discovery of novel potential KIT inhibitors for the treatment of gastrointestinal stromal tumor
Association between CT imaging features and KIT mutations in small intestinal gastrointestinal stromal tumors
The progressive fragmentation of the KIT/PDGFRA wild-type (WT) gastrointestinal stromal tumors (GIST)
Canine and human gastrointestinal stromal tumors display similar mutations in c-KIT exon 11
Syndromic gastrointestinal stromal tumors
Motesanib inhibits Kit mutations associated with gastrointestinal stromal tumors
TAS-116 inhibits oncogenic KIT signalling on the Golgi in both imatinib-naïve and imatinib-resistant gastrointestinal stromal tumours
Coordinated targeting of CK2 and KIT in gastrointestinal stromal tumours
Germline mutations of KIT in gastrointestinal stromal tumor (GIST) and mastocytosis
Anti-KIT designer T cells for the treatment of gastrointestinal stromal tumor
THZ1 targeting CDK7 suppresses c-KIT transcriptional activity in gastrointestinal stromal tumours
Efficacy of SCF drug conjugate targeting c-KIT in gastrointestinal stromal tumor
Discovery of novel potential KIT inhibitors for the treatment of gastrointestinal stromal tumor
Association between CT imaging features and KIT mutations in small intestinal gastrointestinal stromal tumors
The progressive fragmentation of the KIT/PDGFRA wild-type (WT) gastrointestinal stromal tumors (GIST)
Canine and human gastrointestinal stromal tumors display similar mutations in c-KIT exon 11
Syndromic gastrointestinal stromal tumors
Motesanib inhibits Kit mutations associated with gastrointestinal stromal tumors
TAS-116 inhibits oncogenic KIT signalling on the Golgi in both imatinib-naïve and imatinib-resistant gastrointestinal stromal tumours
Coordinated targeting of CK2 and KIT in gastrointestinal stromal tumours
Germline mutations of KIT in gastrointestinal stromal tumor (GIST) and mastocytosis
Anti-KIT designer T cells for the treatment of gastrointestinal stromal tumor
THZ1 targeting CDK7 suppresses c-KIT transcriptional activity in gastrointestinal stromal tumours
Efficacy of SCF drug conjugate targeting c-KIT in gastrointestinal stromal tumor
Discovery of novel potential KIT inhibitors for the treatment of gastrointestinal stromal tumor
Association between CT imaging features and KIT mutations in small intestinal gastrointestinal stromal tumors
The progressive fragmentation of the KIT/PDGFRA wild-type (WT) gastrointestinal stromal tumors (GIST)
Canine and human gastrointestinal stromal tumors display similar mutations in c-KIT exon 11